Inhibitory układu RAA u hospitalizowanych pacjentów z COVID-19 – wyniki pierwszego randomizowanego badania BRACE CORONA
Renato D. Lopes i wsp. Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19. A Randomized Clinical Trial. JAMA. 2021;325(3):254-264
Among patients hospitalized…
Czytaj więcej